151 related articles for article (PubMed ID: 28493290)
21. Serum biomarkers for thyroid cancer.
Xiao Q; Jia Q; Tan J; Meng Z
Biomark Med; 2020 Jun; 14(9):807-815. PubMed ID: 32677454
[TBL] [Abstract][Full Text] [Related]
22. Development of a sensitive and specific quantitative reverse transcription-polymerase chain reaction assay for blood thyroglobulin messenger ribonucleic acid in the follow-up of patients with differentiated thyroid carcinoma.
Boldarine VT; Maciel RM; Guimarães GS; Nakabashi CC; Camacho CP; Andreoni DM; Mamone Mda C; Ikejiri ES; Kasamatsu TS; Crispim F; Hojaij FC; Hidal JT; Biscolla RP
J Clin Endocrinol Metab; 2010 Apr; 95(4):1726-33. PubMed ID: 20173019
[TBL] [Abstract][Full Text] [Related]
23. Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material.
Kartal K; Onder S; Kosemehmetoglu K; Kilickap S; Tezel YG; Kaynaroglu V
BMC Cancer; 2015 Oct; 15():824. PubMed ID: 26519197
[TBL] [Abstract][Full Text] [Related]
24. Significance of low levels of thyroglobulin in fine needle aspirates from cervical lymph nodes of patients with a history of differentiated thyroid cancer.
Borel AL; Boizel R; Faure P; Barbe G; Boutonnat J; Sturm N; Seigneurin D; Bricault I; Caravel JP; Chaffanjon P; Chabre O
Eur J Endocrinol; 2008 May; 158(5):691-8. PubMed ID: 18426828
[TBL] [Abstract][Full Text] [Related]
25. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer.
Pacini F; Fugazzola L; Lippi F; Ceccarelli C; Centoni R; Miccoli P; Elisei R; Pinchera A
J Clin Endocrinol Metab; 1992 Jun; 74(6):1401-4. PubMed ID: 1592886
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of thyroglobulin assay in cervical lymph node fine-needle aspirations for metastatic differentiated thyroid cancer.
Giovanella L; Bongiovanni M; Trimboli P
Curr Opin Oncol; 2013 Jan; 25(1):6-13. PubMed ID: 23090642
[TBL] [Abstract][Full Text] [Related]
27. [Advances in thyroglobulin assays and their impact on the management of differentiated thyroid cancers].
d'Herbomez M; Lion G; Béron A; Wémeau JL; DoCao C
Ann Biol Clin (Paris); 2016; 74(1):21-7. PubMed ID: 26711165
[TBL] [Abstract][Full Text] [Related]
28. VEGF-C Is a Thyroid Marker of Malignancy Superior to VEGF-A in the Differential Diagnostics of Thyroid Lesions.
Woliński K; Stangierski A; Szczepanek-Parulska E; Gurgul E; Budny B; Wrotkowska E; Biczysko M; Ruchala M
PLoS One; 2016; 11(2):e0150124. PubMed ID: 26900960
[TBL] [Abstract][Full Text] [Related]
29. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
[TBL] [Abstract][Full Text] [Related]
30. Determining tissue origin of circulating epithelial cells (CEC) in patients with differentiated thyroid cancer by real-time PCR using thyroid mRNA probes.
Sorg S; Pachmann K; Brede-Hekimian K; Freesmeyer M; Winkens T
Cancer Lett; 2015 Jan; 356(2 Pt B):491-5. PubMed ID: 25304372
[TBL] [Abstract][Full Text] [Related]
31. [Thyroglobulin RT-PCR method for detection of lymph node metastases during the course of differentiated thyroid cancers].
Gubała E; Handkiewicz-Junak D; Zeman M; Chmielik E; Wiench M; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():349-56. PubMed ID: 12182047
[TBL] [Abstract][Full Text] [Related]
32. Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastases.
Snozek CL; Chambers EP; Reading CC; Sebo TJ; Sistrunk JW; Singh RJ; Grebe SK
J Clin Endocrinol Metab; 2007 Nov; 92(11):4278-81. PubMed ID: 17684045
[TBL] [Abstract][Full Text] [Related]
33. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood.
Biscolla RP; Cerutti JM; Maciel RM
J Clin Endocrinol Metab; 2000 Oct; 85(10):3623-7. PubMed ID: 11061512
[TBL] [Abstract][Full Text] [Related]
34. Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal.
Cherk MH; Francis P; Topliss DJ; Bailey M; Kalff V
Clin Endocrinol (Oxf); 2012 May; 76(5):734-40. PubMed ID: 22050475
[TBL] [Abstract][Full Text] [Related]
35. On-levothyroxine measurement of thyroglobulin is not a reliable test for the follow-up of patients at high risk for remnant/recurrent differentiated thyroid carcinoma.
Gholamrezanezhad A; Saghari M; Mirpour S; Beiki D; Tarbiat A; Javan S; Abdollahzadeh J
Endokrynol Pol; 2007; 58(2):100-4. PubMed ID: 17578824
[TBL] [Abstract][Full Text] [Related]
36. Circulating thyroid stimulating hormone receptor messenger RNA and differentiated thyroid cancer: A diagnostic meta-analysis.
Zhang ZZ; Chen Q; Kong CY; Li ZM; Wang LS
Oncotarget; 2017 Jan; 8(4):6623-6629. PubMed ID: 28036261
[TBL] [Abstract][Full Text] [Related]
37. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
Spencer C; Fatemi S
Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
[TBL] [Abstract][Full Text] [Related]
38. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
39. Detection of circulating thyroid cancer cells in patients with thyroid microcarcinomas.
Novosel T; Ritter HE; Gupta M; Harvey A; Mitchell J; Berber E; Siperstein A; Milas M
Surgery; 2009 Dec; 146(6):1081-9. PubMed ID: 19958935
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse.
Barzon L; Boscaro M; Pacenti M; Taccaliti A; Palù G
Int J Cancer; 2004 Jul; 110(6):914-20. PubMed ID: 15170676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
